Related Experiment Video
Updated: Jun 8, 2026
13:08
Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
Published on: September 9, 2011
Zolendronate associated inflammatory orbital disease
The New Zealand Medical Journal
|October 9, 2010
Summary
Bisphosphonate infusions can cause adverse events. This case report highlights a rare instance of bisphosphonate-induced orbital inflammation linked to zolendronate, a complication not widely recognized.
Area of Science:
- Ophthalmology
- Pharmacology
- Rheumatology
Background:
- Bisphosphonate infusions are common treatments for bone diseases.
- Adverse events affect about one-third of patients receiving bisphosphonates.
- Ocular and orbital inflammatory complications are rare side effects.
Observation:
- A patient receiving zolendronate infusion developed inflammatory orbital disease.
- This presentation is an uncommon manifestation of bisphosphonate therapy.
Findings:
- The case suggests a potential link between zolendronate and orbital inflammation.
- Bisphosphonate-induced orbital inflammation is an under-recognized adverse event.
Implications:
- Clinicians should consider orbital inflammation in patients on bisphosphonates presenting with relevant symptoms.
- Further investigation into this rare complication may be warranted.
- This case adds to the limited literature on bisphosphonate-associated ocular and orbital adverse events.